These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 833295)

  • 21. Personality characteristics of adolescent amphetamine users as measured by the MMPI.
    Brook R; Kaplun J; Whitehead PC
    Br J Addict Alcohol Other Drugs; 1974 Mar; 69(1):61-6. PubMed ID: 4155641
    [No Abstract]   [Full Text] [Related]  

  • 22. The Watson and the Hovey MMPI scales: do they measure organicity or "functional" psychopathology?
    Ruff CF; Ayers JL; Templer DI
    J Clin Psychol; 1977 Jul; 33(3):732-4. PubMed ID: 893702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of religion on sexual self-perception and sexual satisfaction in patients suffering from schizophrenia and depression.
    Peitl MV; Peitl V; Pavlovic E
    Int J Psychiatry Med; 2009; 39(2):155-67. PubMed ID: 19860074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The schizophrenia-organicity (SC-O) and psychiatric-organic (P-O) MMPI scales: a review.
    Watson CG
    J Clin Psychol; 1984 Jul; 40(4):1008-23. PubMed ID: 6480835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of overreported psychopathology with the MMPI-2-RF [corrected] validity scales.
    Sellbom M; Bagby RM
    Psychol Assess; 2010 Dec; 22(4):757-67. PubMed ID: 21133544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of discriminative "power" of the MMPI with older psychiatric patients.
    Davis WE; Mozdzierz GJ; Macchitelli FJ
    J Pers Assess; 1973 Dec; 37(6):555-8. PubMed ID: 4148858
    [No Abstract]   [Full Text] [Related]  

  • 27. Does the disorder matter? Investigating a moderating effect on coached noncredible overreporting using the MMPI-2 and PAI.
    Veltri CO; Williams JE
    Assessment; 2013 Apr; 20(2):199-209. PubMed ID: 23118265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a three-scale MMPI: the MMPI-TRI.
    Swanson SC; Tmepler DI; Thomas-Dobson S; Cannon WG; Streiner DL; Reynolds RM; Miller HR
    J Clin Psychol; 1995 May; 51(3):361-74. PubMed ID: 7560136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MMPI and Rorschach indices of schizophrenic and depressive diagnoses among adolescent inpatients.
    Archer RP; Gordon RA
    J Pers Assess; 1988; 52(2):276-87. PubMed ID: 3404390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of hospitalized patients who produce the "floating" MMPI profiles.
    Newmark CS; Sines LK
    J Clin Psychol; 1972 Jan; 28(1):74-6. PubMed ID: 4400456
    [No Abstract]   [Full Text] [Related]  

  • 31. Discriminative dimensions of the MMPI as a function of age and psychopathology.
    Miller TW; Paciello RA
    J Clin Psychol; 1980 Jul; 36(3):758-62. PubMed ID: 7410576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two- and three-point classification of MMPI profiles in which scales 2, 7, and 8 are the highest elevations.
    Kelley CK; King GD
    J Pers Assess; 1980 Feb; 44(1):25-33. PubMed ID: 7359303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MMPI scales and subscales: patterns of older, middle-aged, and younger inpatients.
    Hyer L; Harkey B; Harrison WR
    J Clin Psychol; 1986 Jul; 42(4):596-601. PubMed ID: 3745458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminating between substance abusers with single and dual diagnoses using MMPI profiles and the Mac Andrews Alcoholism Scale: Axis I and Axis II subtypes.
    Rozensky RH; Neirick B; Slotnick GM; Morse D
    Psychol Rep; 1988 Dec; 63(3):985-6. PubMed ID: 3237942
    [No Abstract]   [Full Text] [Related]  

  • 35. Subtypes of adolescents with substance use disorders and psychiatric comorbidity using cluster and discriminant analysis of MMPI-A profiles.
    Magallón-Neri E; Díaz R; Forns M; Goti J; Canalda G; Castro-Fornieles J
    Adicciones; 2012; 24(3):219-27. PubMed ID: 22868977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mental health outcomes in dually diagnosed individuals with mental retardation assessed with the MMPI-168(L): case studies.
    McDaniel WF; Harris DW
    J Clin Psychol; 1999 Apr; 55(4):487-96. PubMed ID: 10348409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Women who seek therapeutic abortion: a comparison with women who complete their pregnancies.
    Ford CV; Castelnuovo-Tedesco P; Long KD
    Am J Psychiatry; 1972 Nov; 129(5):546-52. PubMed ID: 4404065
    [No Abstract]   [Full Text] [Related]  

  • 38. MMPI interpretation of psychiatric inpatients: caution in making inferences about concentration and memory.
    Gass CS; Burda PC; Starkey TW; Dominguez F
    J Clin Psychol; 1992 Jul; 48(4):493-9. PubMed ID: 1355492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex differences on the MMPI-2 substance abuse scales in psychiatric inpatients.
    Wong JL; Besett TM
    Psychol Rep; 1999 Apr; 84(2):582-4. PubMed ID: 10335071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The adequacy of the MMPI-2 Harris-Lingoes subscales: a cross-cultural factor analytic study of Scales D, Hy, Pd, Pa, Sc, and Ma.
    Almagor M; Koren D
    Psychol Assess; 2001 Jun; 13(2):199-215. PubMed ID: 11433795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.